What is Zacks Research's Forecast for Perrigo Q1 Earnings?

Perrigo Company plc (NYSE:PRGO - Free Report) - Zacks Research reduced their Q1 2025 earnings estimates for Perrigo in a note issued to investors on Thursday, March 20th. Zacks Research analyst S. Ganoria now anticipates that the company will post earnings of $0.44 per share for the quarter, down from their prior forecast of $0.52. The consensus estimate for Perrigo's current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo's Q2 2025 earnings at $0.70 EPS, Q3 2025 earnings at $0.79 EPS, FY2025 earnings at $2.93 EPS, Q1 2026 earnings at $0.55 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $0.83 EPS, Q4 2026 earnings at $0.99 EPS, FY2026 earnings at $3.20 EPS and FY2027 earnings at $3.51 EPS.

Several other analysts have also recently weighed in on the stock. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Finally, Piper Sandler cut Perrigo from an "overweight" rating to a "neutral" rating and dropped their price target for the company from $34.00 to $27.00 in a report on Monday, January 6th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $33.00.

Remove Ads

Perrigo Price Performance

Shares of PRGO traded up $0.38 during trading hours on Monday, hitting $27.74. The stock had a trading volume of 1,143,740 shares, compared to its average volume of 1,431,719. Perrigo has a 52 week low of $23.14 and a 52 week high of $33.46. The stock has a market capitalization of $3.79 billion, a price-to-earnings ratio of -23.71 and a beta of 0.48. The company's fifty day moving average is $25.95 and its two-hundred day moving average is $26.14. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.

Perrigo (NYSE:PRGO - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.20 billion.

Perrigo Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were paid a dividend of $0.29 per share. This is a boost from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a dividend yield of 4.18%. The ex-dividend date was Friday, March 7th. Perrigo's dividend payout ratio is -92.80%.

Insider Buying and Selling

In related news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of PRGO. Price T Rowe Associates Inc. MD boosted its position in shares of Perrigo by 6,828.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,845,539 shares of the company's stock worth $201,710,000 after purchasing an additional 7,732,309 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Perrigo by 229.2% during the 3rd quarter. Wellington Management Group LLP now owns 2,697,698 shares of the company's stock worth $70,761,000 after acquiring an additional 1,878,145 shares in the last quarter. FMR LLC raised its holdings in shares of Perrigo by 66,795.3% in the third quarter. FMR LLC now owns 1,840,289 shares of the company's stock valued at $48,271,000 after purchasing an additional 1,837,538 shares during the last quarter. Norges Bank acquired a new position in Perrigo during the fourth quarter worth $36,614,000. Finally, Ion Asset Management Ltd. grew its position in Perrigo by 50.1% in the fourth quarter. Ion Asset Management Ltd. now owns 2,820,000 shares of the company's stock valued at $72,502,000 after purchasing an additional 941,667 shares in the last quarter. Institutional investors own 95.91% of the company's stock.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.